Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation

Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation

Vincenzo Russo,1 Andrea Paccone,2 Anna Rago,1 Valeria Maddaloni,3 Dario Iafusco,4 Riccardo Proietti,5 Umberto Atripaldi,3 Antonio D’Onofrio,1 Paolo Golino,1 Gerardo Nigro1 1Chair of Cardiology, University of Campania “Luigi Vanvitelli”- Monaldi Hospital, Naples, Italy;...

Full description

Bibliographic Details
Main Authors: Russo V, Paccone A, Rago A, Maddaloni V, Iafusco D, Proietti R, Atripaldi U, D'Onofrio A, Golino P, Nigro G
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Journal of Blood Medicine
Subjects:
atrial fibrillation
obesity
non vitamin k oral anticoagulant
plasma levels
apixaban
weight loss
Online Access:https://www.dovepress.com/apixaban-in-a-morbid-obese-patient-with-atrial-fibrillation-a-clinical-peer-reviewed-article-JBM

Internet

https://www.dovepress.com/apixaban-in-a-morbid-obese-patient-with-atrial-fibrillation-a-clinical-peer-reviewed-article-JBM

Similar Items